1 / 3 股东名 称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押数 量（股） 占其所 持股份 比例 占公司 总股本 比例 是否为限 售股（如 是，注明 限 售 类 型） 是否 为补 充质 押 质押起始日 质押 到期 日 质权人 质押 用途 新华都 实业集 团股份 有限公 司 否 17,500,000 4.02% 0.98% 否 否 2025-10-27 至办 理解 除质 押之 日止 中国工 商银行 股份有 限公司 福州五 四支行 融资 担保 合计 / 17,500,000 4.02% 0.98% / / / / / / 一、本次股份质押基本情况 二、股东股份累计质押情况 截至本公告披露日，新华都及其一致行动人所持质押股份情况如下： 股票代码：000538 股票简称：云南白药 公告编号：2025-47 云南白药集团股份有限公司 关于股东部分股份质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近 日接到公司股东新华都实业集团股份有限公司（以下简称"新华都"）的通 知，获悉新华 ...

Group 1 - Yunnan Baiyao announced that as of the date of the announcement, Xinhua Duhua Industrial Group Co., Ltd. and its concerted parties have pledged a total of approximately 148 million shares, accounting for 33.03% of their held shares [1] - For the first half of 2025, Yunnan Baiyao's revenue composition is as follows: commercial sales account for 59.78%, industrial sales account for 40.01%, other businesses account for 0.1%, technical development services account for 0.08%, and hotel and catering industry account for 0.03% [1] - As of the time of reporting, Yunnan Baiyao's market capitalization is 100.1 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology as the main driver reshaping the market and initiating a new "slow bull" pattern [1]

Core Insights - Yunnan Baiyao Group has established a smart factory that can produce up to 1.6 million toothpaste tubes daily, with an annual capacity of 450 million tubes and other products [1] - The factory aims to represent China's health industry in global competition by adopting "Industry 4.0" standards and focusing on production transformation and upgrading [1][3] - The smart factory has been recognized as a "lighthouse factory" in global manufacturing, showcasing its advanced capabilities [1] Digital Transformation - The factory has implemented a comprehensive data governance system, standardizing data across over 50 core business systems and establishing a robust data management framework [2] - It utilizes 7,500 sensors to create a data perception network, enabling real-time monitoring and predictive maintenance through AI algorithms [2] - The integration of IoT technology has led to innovations such as "one-step paste production" and "second-level switching," significantly enhancing production efficiency [2] Production Efficiency - The smart factory's digital and modular production approach allows for rapid response to diverse market demands, facilitating a quick feedback loop from market to production and back [3] - Future plans include deepening digital transformation and applying smart manufacturing models to other product lines, such as traditional Chinese medicine and health foods [3] - The factory aims to provide intelligent manufacturing solutions to assist other manufacturers in reducing transformation costs and overcoming technical challenges [3]

Core Insights - Yunnan Baiyao Group has established a smart factory that can produce up to 1.6 million toothpaste tubes daily, with an annual capacity of 450 million tubes and other products [2] - The factory aims to represent China's health industry in global competition by adopting "Industry 4.0" standards and focusing on production transformation and smart manufacturing [2][4] - The smart factory has been recognized as a "lighthouse factory" in global manufacturing, highlighting its advanced operational capabilities [2] Digital Transformation - The factory has implemented a comprehensive data governance system, standardizing data across over 50 core business systems and establishing a robust data management framework [3] - It utilizes 7,500 sensors to create a data perception network, enabling real-time monitoring and predictive maintenance through AI algorithms [3] - The integration of IoT technology has led to innovations such as "one-step paste production" and "second-level switching," significantly enhancing production efficiency [3][4] Production Efficiency - The smart factory's digital and modular production approach allows for rapid response to market demands, accommodating diverse needs across different channels and regions [4] - The factory can quickly switch between 42 different paste formulas, reducing the setup time for production from traditional methods by approximately 95% [3][4] - Future plans include expanding the digital transformation model to other product lines, such as traditional Chinese medicine and health foods, to enhance overall industry efficiency [4][5]

Core Insights - Yunnan Baiyao Group has established a smart factory that can produce up to 1.6 million toothpaste tubes daily, with an annual capacity of 450 million tubes and other products [1] - The factory aims to represent China's health industry in global competition by adopting "Industry 4.0" standards and focusing on production transformation and upgrading [1][3] - The smart factory has been recognized as a "lighthouse factory" in global manufacturing, showcasing its advanced capabilities [1] Digital Transformation - The factory has implemented a comprehensive data governance system, standardizing data across over 50 core business systems and establishing a robust data management framework [2] - It utilizes 7,500 sensors to create a data perception network, enabling real-time monitoring and predictive maintenance through AI algorithms [2] - The integration of IoT technology has led to innovations such as "one-step paste production" and "second-level switching," significantly enhancing production efficiency [2] Production Efficiency - The smart factory's digital and modular production approach allows for rapid response to diverse market demands, facilitating a quick feedback loop from market to production and back [3] - Future plans include deepening digital transformation and applying smart manufacturing models to other product lines, such as traditional Chinese medicine and health foods [3] - The company aims to provide intelligent manufacturing solutions to assist other manufacturers in reducing transformation costs and overcoming technical challenges [3]

Core Viewpoint - Xinhua Group plans to issue exchangeable bonds backed by its shares in Yunnan Baiyao, with a total issuance scale of up to 2 billion RMB [2][4]. Group 1: Exchangeable Bonds Issuance - Xinhua Group intends to issue exchangeable bonds using part of its A-share holdings in Yunnan Baiyao as collateral [2]. - The issuance has received approval from the Shenzhen Stock Exchange, confirming it meets the listing conditions [2]. - The bonds will be managed by Guosen Securities as the nominal holder, with specific accounts set up for the transaction [2]. Group 2: Bond Details - The total issuance scale of the bonds is capped at 2 billion RMB [4]. - The bonds have a coupon rate of 0.1% and a maturity period of 3 years [4]. - The initial conversion price is set at 71.66 RMB per share, with the conversion period starting from April 23, 2026, to October 20, 2028 [4][3].

Core Viewpoint - Yunnan Baiyao Group Co., Ltd. has decided to cancel its supervisory board and amend its articles of association, which will be submitted for approval at the upcoming extraordinary general meeting of shareholders [1][3]. Group 1: Board Meeting Resolutions - The board meeting held on October 24, 2025, approved the cancellation of the supervisory board and the revision of the articles of association in accordance with relevant laws and regulations [1][41]. - The board also approved the revision of the "Rules of Procedure for Shareholders' Meetings," which will now be renamed "Rules of Procedure for Shareholder Meetings" [5]. - The board approved the revision of the "Rules of Procedure for Board Meetings" [8]. - The board approved the revision of the "Rules of Procedure for Office Meetings," which will now be renamed "Rules of Procedure for the President's Office Meetings" [11]. - The board approved the revision of the "Implementation Rules of the Board Strategic Committee," which will now be renamed "Work Regulations of the Board Strategic Committee" [13]. - The board approved the revision of the "Implementation Rules of the Board Audit Committee," which will now be renamed "Work Regulations of the Board Audit Committee" [15]. - The board approved the revision of the "Implementation Rules of the Board Compensation and Assessment Committee," which will now be renamed "Work Regulations of the Board Compensation and Assessment Committee" [17]. - The board approved the revision of the "Implementation Rules of the Board Nomination Committee," which will now be renamed "Work Regulations of the Board Nomination Committee" [19]. - The board nominated candidates for the 11th Board of Directors, which will be submitted for election at the upcoming shareholders' meeting [21][23]. - The board also nominated candidates for independent directors for the 11th Board of Directors, which will also be submitted for election [23][24]. Group 2: Upcoming Shareholder Meeting - The company will hold the 2025 Second Extraordinary General Meeting of Shareholders on November 10, 2025, to review the resolutions passed by the board [27][45]. - The meeting will be conducted in a hybrid format, combining on-site voting and online voting [47]. - Shareholders must register to attend the meeting, and the registration period is from November 4, 2025 [53].

Group 1 - Yunnan Baiyao held its sixth board meeting of the tenth session on October 24, 2025, to review the proposal for amending the "Board Meeting Rules" [1] - For the first half of 2025, Yunnan Baiyao's revenue composition was as follows: commercial sales accounted for 59.78%, industrial sales for 40.01%, other businesses for 0.1%, technical development services for 0.08%, and hospitality and catering for 0.03% [1] - As of the report date, Yunnan Baiyao's market capitalization was 100.6 billion yuan [1] Group 2 - A well-known brand spent 170 million yuan to acquire 2,000 shares of a target company with a registered capital of only 10,000 Hong Kong dollars, which has not yet commenced operations, raising questions about the necessity of the acquisition [1]

云南白药集团股份有限公司 董事会审计委员会工作规程 （2025 年 10 月修订） 第一章 总 则 第一条 为强化云南白药集团股份有限公司（以下简称"公司"）董事会决 策功能，规范公司董事会审计委员会的运作，确保董事会对经营管理层的有效监 督，充分发挥审计在风险防控中的作用，根据《中华人民共和国公司法》《上市 公司治理准则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公 司规范运作》《云南白药集团股份有限公司公司章程》（以下简称《公司章程》） 等相关规定，公司董事会设立审计委员会，并制定本工作规程。 第二条 审计委员会是董事会按照《公司章程》设立的专门工作机构，行使 《公司法》规定的监事会的职权，负责监督及评估公司外部、内部审计工作，监 督及评估公司的内部控制并审核公司的财务信息及其披露。 第三条 本工作规程所称董事、高级管理人员均与《公司章程》规定一致。 第二章 人员组成 第四条 董事会审计委员会委员由五名董事组成，其中独立董事三名，不在 公司担任高级管理人员的董事两名，由独立董事中会计专业人士担任召集人。 会计专业人士应具备较丰富的会计专业知识和经验，并至少符合下列条件之 一：（1）具有注册 ...

云南白药集团股份有限公司 总裁办公会议事规则 （2025 年 10 月修订） 第一章 总则 第一条 为加强集体领导，保证云南白药集团股份有限公司（以 下简称"集团"或"公司"）总裁办公会议事决策的科学化、制度化 和规范化，切实提高总裁办公会议事决策水平和能力，根据《公司章 程》《云南白药集团股份有限公司首席执行官工作细则》、集团董事 会对总裁办公会的授权，结合公司实际，制定本规则。 第二条 总裁办公会坚持"各抒己见、充分讨论，发扬民主、从 善如流，凝聚智慧、集中决策"的原则，支持总裁（首席执行官）科 学有效地实施决策。 第三条 总裁办公会是总裁（首席执行官）对经营管理等工作实 施有效领导的组织形式，总裁办公会最终的决策由总裁（首席执行官） 裁决并为之负责。 第二章 会议召集 第四条 总裁办公会由总裁（首席执行官）召集和主持，总裁（首 席执行官）不能履行职责时，可以委托一名高级副总裁代为召集和主 持。 第三章 参会人员 - 1 - 第五条 参会人员范围为：经营层高级管理人员、行政管理部门 负责人、议题或报告事项拟制单位负责人（只参加该议题或报告事项 的讨论或报告环节）及总裁（首席执行官）认为需参会的其他人员等。 ...